In the courses of our search for bioactive natural products on TRAIL resistance-overcoming activity, the active EtOAc extract from the bark of Celtis tetrandra was chemically investigated. The fractionation of the extract resulted in the isolation of flavanols; (+)-afzelechin (1), (-)- epiafzelechin (2), (-)-catechin (3), and two new flavanol dimers; (-)- epiafzelechin-(4α→8)-(-)-catechin (4) and (-)- epiafzelechin-(4α→8)-(-)- epicatechin (5). All isolated compounds 1-5 were tested for their TRAIL resistance-overcoming activity against AGS cells at the concentrations from 5–20 μM. It is likely that the flavanol dimers 4 and 5 exhibited weak activity in the range of the concentration of 10–20 μM as compared with the standard.
No takes yet. Share an insight, caveat, or question.
Seephonkai et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: